Graciansky A M, Jenison E L
Department of Obstetrics and Gynecology - Akron General Medical Center, Ohio.
Eur J Gynaecol Oncol. 1989;10(5):296-9.
A patient with primary, bulky, Stage III, malignant mixed mesodermal tumor (MMMT) of the ovary achieved a partial response to postoperative cis-Diamminedichloroplatinum (DDP). These rare tumors have previously been relatively resistant to chemotherapeutic agents. The use of DDP resulted in significant palliation in our patient and should be strongly considered in the postoperative therapy of patients with MMMT of the ovary.
一名患有原发性、体积较大的Ⅲ期卵巢恶性混合性中胚叶肿瘤（MMMT）的患者对术后顺二氯二氨铂（DDP）治疗取得了部分缓解。这些罕见肿瘤此前对化疗药物相对耐药。DDP的使用使我们的患者得到了显著缓解，在卵巢MMMT患者的术后治疗中应强烈考虑使用该药物。
